Comparison of sotalol hydrochloride and methyldopa in essential hypertension.
In a non-blind randomized comparison of sotalol hydrochloride and methyldopa in essential hypertension, the two drugs were equivocal in effect in reaching a preset hypotensive aim, in the maximum decreases from the baseline and in the mean reductions per week from the baseline. Milligram for milligram, sotalol was about twice as potent as methyldopa. No volunteered side-effects were noted for methyldopa; 3/19 for sotalol.
D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000009:adverse effects / Q000627:therapeutic use*; D013015:Sotalol / Q000009:adverse effects / Q000627:therapeutic use*
D008750:Methyldopa; D013015:Sotalol